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ABSTRACT: Physiologically important peptides
are often encoded in precursors that contain several
gene products; thus, regulation of expression of polypep-
tide proteins is crucial to transduction pathways. Differ-
ential processing of precursors by cell- or tissue-specific
proteolytic enzymes can yield messengers with diverse
distributions and dissimilar activities. FMRFamide-re-
lated peptides (FaRPs) are present throughout the ani-
mal kingdom and affect both neural and gastrointestinal
functions. Organisms have several genes encoding nu-
merous FaRPs with a common C-terminal structure but
different N-terminal amino acid extensions. We have
isolated SDNFMRFamide, DPKQDFMRFamide, and
TPAEDFMRFamide contained in the Drosophila FMR-
Famide gene. To investigate the regulation of expression
of FMRFamide peptides, we generated antisera to dis-
tinguish among the three neuropeptides. We have pre-
viously reported the distribution of SDNFMRFamide
and DPKQDFMRFamide. In this article, we describe
TPAEDFMRFamide expression. TPAEDFMRFamide
antisera stain cells in embryonic, larval, pupal,
and adult thoracic and abdominal ganglia. In addi-
tion, TPAEDFMRFamide-immunoreactive material is
present in a lateral protocerebrum cell in adult. Thus,
TPAEDFMRFamide antisera staining of neural tissue is
different from SDNFMRFamide or DPKQDFMRF-
amide. In addition, TPAEDFMRFamide antisera stain
larval, pupal, and adult gut, while SDNFMRFamide and
DPKQDFMRFamide do not. TPAEDFMRFamide im-
munoreactivity is present in cells stained by FMRF-
amide antisera. Taken together, these data support the
conclusion that TPAEDFMRFamide is differentially
processed from the FMRFamide polypeptide protein
precursor and may act in both neural and gastrointes-
tinal tissue. © 1999 John Wiley & Sons, Inc. J Neurobiol 39: 347–358,
1999
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Peptides play roles in many critical biological func-
tions; thus, it is crucial to decipher regulation of
peptide expression and signaling. Bioactive peptides
are frequently present in precursors that contain mul-
tiple structurally related gene products and homologs
of neuropeptides often exist in gastrointestinal tissue.
Establishing the distribution of physiologically rele-
vant messengers provides insight into regulation of
gene expression and peptide activity.
One family of peptides has a common C-terminal
FMRFamide but distinct N-terminal extension. It is
thought that the C-terminus is essential for binding,
while the unique residues of a peptide confer differ-
ences in activity (Raffa, 1988). FMRFamide, isolated
as a cardioexcitatory peptide (Greenberg and Price,
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1977), has been shown to elicit a wide variety of
responses (Weiss et al., 1984; Robb et al., 1989; Day
et al., 1994; Franks et al., 1994; Wang and Orchard,
1995). In addition, FMRFamide antisera have been
used to identify immunoreactive materials and isolate
peptides from numerous organisms (Dockray et al.,
1983; Yang et al., 1985; Nichols, 1992a,b; Lange et
al., 1994; Voronezhskaya and Elekes, 1996; Witten
and Truman, 1996; Armstrong et al., 1997). The con-
servation of structure, function, spatial and temporal
distribution, and abundance of FMRFamide peptides
suggests that they play important roles in animal
physiology.
Typically, organisms have more than one gene
encoding multiple FMRFamide peptides (Nambu et
al., 1988; Nichols et al., 1988; Marks et al., 1997).
There is evidence for alternative splicing to produce
different FMRFamide transcripts and products (Saun-
ders et al., 1992; Bright et al., 1993; Santama et al.,
1995; Price et al., 1997), and differential posttransla-
tional processing of FMRFamide polypeptide precur-
sors results in cell-specific expression patterns (San-
tama et al., 1993; Nichols et al., 1995a,b; Santama et
al., 1997). The complexity of processing that FMRF-
amide precursors undergo provides an animal with a
diverse array of gene products to affect a variety of
physiological parameters.
We are studying the expression and processing of
FMRFamide-containing gene products inDrosophila
melanogaster(Nichols et al., 1988, 1995a,b; Nichols,
1992a,b, 1997; McCormick and Nichols, 1993; Ni-
chols and Lim, 1996). ThreeDrosophila genes,
dromyosuppressin (Dms) (Nichols, 1992a), drosulfa-
kinin (Dsk) (Nichols et al., 1988), and FMRFamide
(Nambu et al., 1988; Schneider and Taghert, 1988),
encode numerous FMRFamide peptides. We have iso-
lated DPKQDFMRFamide, SDNFMRFamide, and
TPAEDFMRFamide (Nichols, 1992a,b) from the
DrosophilaFMRFamide gene.
Antisera to FMRFamide have been used to identify
peptides in theDrosophila central nervous system
(White et al., 1986; Chin et al., 1991; O’Brien et al.,
1991; Schneider et al., 1991). While informative,
these data are difficult to interpret because FMRF-
amide antisera do not distinguish among the numer-
ous structurally related peptides. In addition, antisera
to the FMRFamide precursor do not provide informa-
tion on the distribution of individual FMRFamide
peptides processed from the gene (Schneider et al.,
1993).
Here, we present TPAEDFMRFamide expression.
TPAEDFMRFamide immunoreactivity is present in
the central nervous system and midgut at all stages of
development. Although TPAEDFMRFamide-immu-
noreactive material is present in cells stained by
FMRFamide antisera, it is not colocalized with DP-
KQDFMRFamide (Nichols et al., 1995a) or SDNFM-
RFamide (Nichols et al., 1995b). In addition, the
distribution of TPAEDFMRFamide is a subset of that
described for the FMRFamide precursor (Schneider et
al., 1993). These data support the conclusion that the
Drosophila FMRFamide polypeptide protein precur-
sor is differentially processed on a cellular level to
yield unique distributions of structurally related pep-
tides that may have diverse activities.
MATERIALS AND METHODS
Antigen Design
To generate antisera that would distinguish among the
knownDrosophilaFMRFamide peptides and determine the
expression of TPAEDFMRFamide, we raised antisera to
TPAED-multiple antigenic peptide (MAP) (Postnett and
Tam, 1989; Nichols et al., 1997). The five amino acid
residues of the antigen represent the unique N-terminal
extension of TPAEDFMRFamide and do not include the
common FMRFamide C-terminal structure, thus avoiding
the generation of antisera that would recognize FMRFamide
or otherDrosophilaFMRFamide peptides. We chose to use
an MAP antigen to maximize antigenicity and eliminate the
need to conjugate the antigen to a carrier protein.
Antisera Generation
Antisera were raised in female New Zealand white rabbits
as previously described (Nichols et al., 1995a,b). All pro-
tocols were approved by the University of Michigan Com-
mittee on Use and Care of Animals. Sera were assayed as
previously described (White et al., 1986; McCormick and
Nichols, 1993).
Antisera Purification
Crude antisera were purified on affinity column resin made
by conjugating TPAED-MAP to Affi-gel 10 (BioRad Lab-
oratories) according to the manufacturer’s instructions, and
equilibrated in 53 phosphate-buffered saline (PBS). The
purification protocol was previously described (Nichols et
al., 1995a,b; Nichols et al., 1997).
The specificity of the antisera was determined by design-
ing the antigen to the N-terminal amino acid residues dis-
tinguishing TPAEDFMRFamide from FMRFamide and
other Drosophila FMRFamide peptides. In addition, the
method of purification selected for antisera recognizing
TPAEDFMRFamide. Specificity was confirmed by preab-
sorbing the affinity-purified antisera with 1024 M TPAED-
MAP or FMRFamide prior to use in immunolocalization.
We refer to the affinity-purified peptide-specific antisera as
TPAEDFMRFamide antisera.
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Animals
Drosophila melanogasterOregon R flies were maintained
on cornmeal molasses media at 25°C. At each developmen-
tal period, neural tissue was dissected from flies of a known
age. Animals were collected for dissection based on the
number of hours after egg laying for embryos, after hatching
for larvae, after becoming white prepupae for pupae, and
after eclosing for adults. Central nervous system tissue was
dissected from 15- to 16-h embryos, 24-, 48-, 72-, and 96-h
larvae, 24-, 48-, 72-, and 90-h pupae, and 3- and 7-day
adults. Gastrointestinal tissue was dissected from wandering
stage third-instar larvae, pupae, and 7-day adults. No dif-
ference in staining was observed between female and male
flies.
Immunolocalization
Immunolocalization was performed as previously described
(White et al., 1986; McCormick and Nichols, 1993; Nichols
et al., 1995a,b). Briefly, tissue was dissected in Ca21-free
Ringer’s solution (130 mM NaCl, 4.7 mM KCl, 1.8 mM
MgCl2, 0.74 mM Na2HPO4, pH 7) and fixed in 4% para-
formaldehyde for 4–6 h at 4°C. After a thorough wash in
PTN [0.1 mM NaPO4, 0.3% Triton X-100, 0.1% NaAzide,
0.1% bovine serum albumin (BSA)], the tissue was incu-
bated in primary antisera overnight at 4°C with a slow
rotatory motion, rinsed in PTN, and then placed in goat
anti-rabbit Cy3-conjugated secondary antisera (Jackson Im-
munoResearch Laboratories) for 4–6 h at 4°C. After exten-
sive washing in PTN, the tissue was rinsed in 4 mM NaCar-
bonate, pH 9, before being mounted in 80% glycerol
containing 5% propyl gallate under a glass coverslip.
Double-label immunolocalization was performed as pre-
viously described (Nichols et al., 1995a,b). Rabbit anti-
FMRFamide (Peninsula Laboratories) was detected by flu-
orescein isothiocyanate (FITC)-labeled goat anti-rabbit
second antibody (Sigma Chemical Corp.).
Data Collection and Analysis
Data were collected on a BioRad 600 Kr-Ar laser confocal
attached to a Nikon inverted microscope using K1 and K2
filters and a320 or 340 objective. Optical sections or z
series were collected using the CoMos program. Adobe
photoshop software, version 3.0, was used to process the
data, and images were printed with a Kodak XLS8600
printer.
RESULTS
The terminology used to identify the cells stained by
antisera is consistent with previous publications
(White et al., 1986; Schneider et al., 1993). Immuno-
reactivity was observed bilaterally symmetric to the
midline; thus, reference to one cell indicates the pres-
ence of a pair of cells positioned bilaterally symmetric
to one another. Signal intensity was strong and con-
sistent, and eight or more preparations were analyzed
for each experiment.
TPAEDFMRFamide immunoreactivity in embry-
onic neural tissue is shown in Figure 1. Staining was
present in the nerve cord or ventral ganglion, a fused
ganglion composed of three thoracic ganglia and eight
abdominal ganglia. The antisera stained 11 cells near
the midline of the embryonic ventral ganglion posi-
tioned anteriorly to posteriorly along the length of the
ganglion in a row or chainlike formation. There was
one cell in each of the three thoracic ganglia and a cell
Figure 1 TPAEDFMRFamide-immunoreactive material
in 15- to 16-h embryonic neural tissue. TPAEDFMRFamide
immunoreactivity is present in 13 cells in the embryonic
nerve cord at 15–16 h. Eleven cells (arrows and arrowheads)
form a chain anteriorly to posteriorly along the midline of
the ventral ganglion. The 11 cells consist of one cell in each
of the three thoracic ganglia (arrowhead) and one per ab-
dominal ganglion (arrow). Immunoreactive processes ex-
tend from these cells toward the midline and project ante-
riorly into the subesophageal ganglion. The processes also
extend contralaterally across the midline forming commis-
sure-like boxes (asterisk). Two additional cells (open arrow-
head), positioned lateral to the chain of cells, one in the
second thoracic ganglion, one in the third thoracic ganglion,
are stained with antisera. Bar5 50 mm.
FMRFamide Gene Expression 349
per abdominal ganglion, thus accounting for the pres-
ence of 11 cells. There were two other immunoreac-
tive cells positioned lateral relative to the chain. These
cells, one in the second and one in the third thoracic
ganglion, were located ventral relative to the row of
cells in the thoracic and abdominal ganglia. An im-
munoreactive process extended from each stained tho-
racic and abdominal cell to the midline, where it
turned and projected into the subesophageal ganglion.
In addition to extending into the subesophageal gan-
glion, these immunoreactive fibers extended con-
tralaterally across the ventral ganglion midline to
form a series of commissure-like connectives or
boxes.
The TPAEDFMRFamide antisera staining pattern
observed in the first-instar larval central nervous sys-
tem resembled that present in the embryonic ventral
ganglion (Fig. 2). One noticeable difference between
the staining in the embryo and the larva was that the
processes along the midline of the ventral ganglion
extended further into the brain and began to encircle
the esophageal opening. In addition, the boxes made
by the processes projecting from the ventral ganglion
cells were more defined, forming what resembled a
ladder along the length of the nerve cord midline. In
third-instar larval neural tissue, the TPAEDFMRF-
amide-immunoreactive fibers that projected from the
ventral ganglion cells completely surrounded the
esophageal opening (Fig. 3). The cells in the nerve
cord were intensely stained and there was an addi-
tional cell in the first thoracic ganglion that expressed
TPAEDFMRFamide. With the staining of an addi-
tional cell in the first thoracic ganglion, each of the
three thoracic ganglia contained two immunoreactive
cells. Several cells in the subesophageal ganglion and
brain lobes were detected with antisera although less
intensely compared to the ventral ganglion cells. No
processes appeared to extend from these subesopha-
geal ganglion and brain lobe cells.
TPAEDFMRFamide-immunoreactive material was
also expressed in the 24-h pupal central nervous sys-
tem (Fig. 4). The cells stained by antisera in the pupal
thoracic ganglion appeared to shift in position as a
result, most likely, of morphological changes; how-
ever, the overall pattern and number of these cells
remained constant. Also, at this time in development,
the immunoreactive fibers that projected from the
ventral ganglion cells to encircle the esophageal open-
ing branched laterally projecting into the brain (Fig.
4). Compared to 24-h pupa, the arborization of these
projections observed in 72-h pupa was increased with
TPAEDFMRFamide-immunoreactive fibers extend-
ing through the brain into the optic lobes (Fig. 5).
While faint signal was visible in cells near the esoph-
agus in 72-h pupa, the signal intensity in the ventral
ganglion cells and processes remained unchanged.
In adult neural tissue, the number of immunoreac-
tive cells present in the nerve cord decreased by one
(Fig. 6). The thoracic and abdominal ganglia of the
adult ventral ganglion contained 13 immunoreactive
cells, with one thoracic ganglion cell no longer ex-
pressing TPAEDFMRFamide. There remained, how-
ever, one immunoreactive cell in the first thoracic
ganglion, two cells in the second thoracic ganglion,
two cells in the third thoracic ganglion, and one cell
per abdominal ganglion that stained with antisera as
seen in earlier stages of development. The processes
from these cells maintained their signal intensity and
contributed to the increased arborization in the ventral
ganglion. The immunoreactive projections that origi-
Figure 2 TPAEDFMRFamide-immunoreactive material
in first-instar larval neural tissue. TPAEDFMRFamide im-
munoreactivity continues to be expressed in cells in the
nerve cord and the processes extending from them. The
number of cells expressing TPAEDFMRFamide is consis-
tent from embryo to first-instar larva: one cell in the first
thoracic ganglion, two in the second and third ganglia, and
one per abdominal ganglia. However, the processes project-
ing from these cells begin to encircle to the esophageal
opening (arrow) in the first-instar neural tissue more com-
pletely than seen in the embryo. Bar5 50 mm.
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nated from the nerve cord cells and encircled the
esophageal opening were still present. There was an
extensive increase in the complexity of the arboriza-
tion of the immunoreactive fibers throughout the brain
and the optic lobes. In addition, there was one cell in
the adult lateral protocerebrum that stained with
TPAEDFMRFamide antisera.
We observed TPAEDFMRFamide immunoreactiv-
ity in 12 cells in the larval anterior midgut (Fig. 7). No
immunoreactive processes were associated with these
cells. The signal intensity was moderate compared to
the signal present in the ventral ganglion cells. Sim-
ilarly, several cells in the pupal gut (data not shown)
and in the adult anterior midgut also contained
TPAEDFMRFamide-immunoreactive material (Fig.
8). No TPAEDFMRFamide immunoreactivity was
observed in any other region of the gastrointestinal
tract at any developmental period examined.
Double-label immunolocalization using TPAED-
FMRFamide-specific antisera and FMRFamide anti-
sera in the same tissue demonstrated that the TPAED-
FMRFamide-immunoreactive ventral ganglion cells
were a subset of cells containing FMRFamide-like
material (Fig. 9). The same double-label immunolo-
calization protocol showed that the midgut cells
stained by TPAEDFMRFamide antisera were a subset
of cells containing FMRFamide immunoreactivity
(Fig. 9).
DISCUSSION
Regulation of neuropeptide signaling is critical to
physiology; hence, several modulatory mechanisms
exist. One mode of regulation is at the posttransla-
tional level with cell-specific proteolytic processing
enzymes cleaving a polypeptide protein precursor to
produce neuropeptides in unique expression patterns
(Curry et al., 1991; LeBlanc et al., 1991; Brand et al.,
1993; Mineo et al., 1995). Elucidating regulatory
mechanisms involved in peptide expression is essen-
tial for understanding neurotransmission. The study of
an abundant, diverse family of neuropeptides provides
physiologically important information relevant to pro-
cessing, structure–activity relationship, and function.
ThreeD. melanogastergenes, Dms, Dsk, and FM-
Figure 4 TPAEDFMRFamide-immunoreactive material
in 24-h pupal neural tissue. TPAEDFMRFamide immuno-
reactivity continues to be expressed during metamorphosis.
The distribution of the peptide in early pupal central ner-
vous system is similar to that of third-instar larval neural
tissue In the pupal central nervous system, however, the
processes that extend from the ventral ganglion cells around
the esophageal opening begin to arborize laterally into the
brain lobes (arrow). Bar5 50 mm.
Figure 3 TPAEDFMRFamide-immunoreactive material
in third-instar larval neural tissue. TPAEDFMRFamide dis-
tribution is present in cells of the nerve cord in the third-
instar larva. There is an additional immunoreactive cell in
the first thoracic ganglion. The two cells in the first thoracic
ganglion are marked by arrows and T1, two cells in the
second are indicated with arrows and T2, and the two cells
in the third ganglion are shown with arrows and T3. Cells in
the subesophageal ganglion (arrow and SE) and brain lobe
(unlabeled arrow) are stained with TPAEDFMRFamide an-
tisera. Bar5 50 mm.
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RFamide, are known to encode several structurally
related FMRFamide peptides (Nambu et al., 1988;
Nichols et al., 1988; Schneider and Taghert, 1988,
McCormick et al., 1993). We have reported the iso-
lation and structure analysis of threeDrosophilaFM-
RFamide peptides, DPKQDFMRFamide, SDNFMR-
Famide, and TPAEDFMRFamide (Nichols, 1992a,b).
We raised antisera specific to DPKQDFMRFamide
and SDNFMRFamide and determined their spatial
and temporal distribution (Nichols et al., 1995a,b).
The expression of TPAEDFMRFamide has not been
described. To elucidate the distribution of TPAED-
FMRFamide, we raised antisera to an antigen repre-
senting the unique N-terminal extension of the peptide
and performed whole-mount immunolocalization on
both neural and gastrointestinal tissue.
A prominent feature of TPAEDFMRFamide ex-
pression at all stages of development was the staining
of nerve cord cells and the immunoreactive fibers that
extended from these cells and projected into the sub-
esophageal ganglion (Figs. 1–6). The number and
position of cells stained were constant and the signal
was strong, suggesting that TPAEDFMRFamide
plays an important role(s) throughout the life of the
animal. The quantity and complexity of the immuno-
reactive ventral ganglion cells and associated projec-
tions implied that there may be several sources of
input into the release of TPAEDFMRFamide and
numerous sites of TPAEDFMRFamide action.
The appearance of processes around the esopha-
geal opening during development implies that
TPAEDFMRFamide has a role(s) relative to the func-
tion of the esophagus (Figs. 1–6). The origin of fibers
suggests that there are multiple sources from which
information can be derived to affect release at this
site(s). Our method of dissecting neural tissue from
surrounding and attached tissue does not allow us to
track the TPAEDFMRFamide innervation to its full
extent. However, we know from our analysis of gas-
trointestinal tissue that TPAEDFMRFamide-contain-
ing fibers do not terminate directly on the foregut.
This does not preclude that the peptide is released
from these nerve endings to act on other neurons that
directly innervate the esophagus and/or gut.
Fibers extended into the subesophageal ganglion
and brain, and projections from the thoracic and ab-
Figure 6 TPAEDFMRFamide-immunoreactive material
in neural tissue from 3-day adult. TPAEDFMRFamide con-
tinues to be expressed in cells and processes in the adult
ventral ganglion and brain. The brain and optic lobe immu-
noreactive processes have significantly increased in number
and complexity. In addition, a lateral protocerebrum cell is
stained intensely with TPAEDFMRFamide antisera (ar-
row). Bar5 50 mm.
Figure 5 TPAEDFMRFamide-immunoreactive material
in 72-h pupal neural tissue. TPAEDFMRFamide immuno-
reactivity in the ventral ganglion is not altered as the animal
continues through metamorphosis. Several cells in the sub-
esophageal ganglion are stained (arrow labeled SE). The
immunoreactive processes that encircle the esophageal
opening continue to extend laterally into the brain lobes
(unlabeled arrow) and at the 72-h pupal stage have reached
the optic lobes. Bar5 50 mm.
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dominal cells crossed the midline to form commis-
sures to give the fasiculating neurites a ladderlike
appearance along the length of the nerve cord that is
present throughout development (Figs. 1–6). The con-
tinued presence of these projections stained with
TPAEDFMRFamide antisera implies that this region
may constitute an important peptidergic release
site(s).
The immunoreactive processes at the midline of
the ventral ganglion (Figs. 1–6) coincided with a
neuronal sheath that has been described as one of two
neurohemal release sites inDrosophilaand the blow-
fly, Calliphora vomitoria (Raabe, 1989; Lundquist
and Nässel, 1990; Na¨ssel et al., 1994). It has been
reported that subesophageal neurons inCalliphora
send processes to this neurohemal region and release
serotonin into the circulation at this site (Na¨ssel and
Elekes, 1985; Trimmer, 1985). This is notable be-
cause of the precedence for the interaction of FMR-
Famide peptides with serotonin (Brownlee et al.,
1995; Wurden and Homberg, 1995). Furthermore,
consistent with this expression of TPAEDFMRF-
amide, FMRFamide-like materials are reported to
have neurohormonal functions (Myers and Evans,
1985; Carroll et al., 1986; Jagdale and Gordon, 1994;
Schoofs et al., 1997). In addition, FMRFamide-immu-
noreactive material has been observed to be released
from peptidergic fibers of theCalliphora dorsal
sheath (Na¨ssel et al., 1994).
TPAEDFMRFamide immunoreactivity in the optic
lobes (Figs. 4–6) implies that the peptide may play a
role in phototransduction or associated neural func-
tions. TPAEDFMRFamide staining is present in the
lobula, an area in which there are a number of neurons
that sense motion and direction relaying messages to
the appropriate neural centers (Strausfeld, 1976, 1984;
Mobbs, 1985). Thus, TPAEDFMRFamide may be
involved in communicating some aspect of motion.
The TPAEDFMRFamide-immunoreactive adult
lateral protocerebral cell (Fig. 6) is located in the
Figure 7 TPAEDFMRFamide-immunoreactive material in the third-instar larval gastrointestinal
tract. TPAEDFMRFamide is present in 12 cells in the anterior midgut. No processes can be seen to
extend from the cells. (Top) Whole larval gastrointestinal tract; left is anterior and right is the
posterior. (Bottom) Enlargement of the region within the rectangle (top). It is the area of the midgut
containing the cells expressing TPAEDFMRFamide-immunoreactive material. Bar5 50 mm.
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region of the antennal lobe where sensory information
detected by the antennae is processed (Mobbs, 1985).
The appearance of signal in this cell in the adult, the
stage when the antennae are functional, may indicate
that TPAEDFMRFamide is involved in sensory stim-
uli signaling. This is in agreement with what is found
in other organisms, where FMRFamide peptides act to
relay sensory information in neural tissue as indicated
by immunolocalization and electrophysiological data
(Umino and Dowling, 1991; Cowden et al., 1993;
Wikgren and Fagerholm, 1993; Xu et al., 1994).
The cells in the anterior midgut containing
TPAEDFMRFamide immunoreactivity (Figs. 7 and
8) are present in the region of the gastrointestinal tract
where digestion and absorption occur (Demerec,
1950). Peptidergic cells are present in this region of
the midgut inDrosophila, Calliphora, and other in-
sects (Zitnan et al., 1993, Na¨ssel et al., 1994). Gut
endocrine cells may function to perceive nutrient con-
tent and/or tension of the muscle wall (Fujita et al.,
1988). The action of these cells is probably local and
may affect gut movement, production of digestive
enzymes, circulation in the digestive tissue, and/or
epithelial shedding. The presence of TPAEDFMRF-
amide in the anterior midgut suggests that it may be
involved in these gastrointestinal processes.
Since our antisera recognized the N-terminal
amino acid residues of TPAEDFMRFamide and not
the C-terminal FMRFamide, we performed double
immunolabeling experiments to confirm that TPAED-
FMRFamide antisera staining was coincident with
FMRFamide-immunoreactive material. Our double-
label immunolocalization with TPAEDFMRFamide
antisera and FMRFamide antisera showed that the
TPAEDFMRFamide staining was a subset of FMRF-
amide immunoreactivity in both neural and gut tissues
(Fig. 9). In neural tissue (Fig. 9, upper panel), FMR-
Famide-stained cells were labeled with secondary an-
tisera conjugated to FITC (green), while the TPAED-
FMRFamide-containing cells were labeled with a
secondary antisera conjugated to Cy3 (red). Overlap
of the green and red fluorescence signals produced
yellow and demonstrated that TPAEDFMRFamide
was expressed in a subset of cells also stained with
FMRFamide antisera. In the gastrointestinal tract
(Fig. 9, lower panel), TPAEDFMRFamide was
present in cells also stained with FMRFamide anti-
sera. Cy3-conjugated secondary antisera (red) recog-
nized TPAEDFMRFamide antisera and FITC (green)-
labeled secondary antisera recognized FMRFamide
antisera. Yellow fluorescence resulted when TPAED-
FMRFamide antisera bound antigen in a subset of
cells stained with FMRFamide antisera. Thus, it is
likely that our peptide-specific TPAEDFMRFamide
antisera recognized TPAEDFMRFamide and not a
substance with a structurally similar N-terminus. This
argument is also supported by the fact that the
TPAEDFMRFamide expression pattern is contained
within the distribution of theDrosophilaFMRFamide
transcript and precursor (O’Brien et al., 1991; Schnei-
der et al., 1991, 1993).
Together with previous studies (Nichols et al.,
1995a,b), these immunolocalization data indicate that
the DrosophilaFMRFamide gene products DPKQD-
FMRFamide, SDNFMRFamide, and TPAEDFMRF-
amide have unique spatial and temporal distributions
(Fig. 10). DPKQDFMRFamide antisera stain cells in
each of the three thoracic ganglia, one cell in the
Figure 8 TPAEDFMRFamide immunoreactivity in the 3-day adult gastrointestinal tract. TPAED-
FMRFamide immunoreactivity is present in several cells of the gastrointestinal tract in the adult
anterior midgut. Bar5 50 mm.
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Figure 9 (Upper) TPAEDFMRFamide/FMRFamide third-instar larval neural tissue double-label
immunofluorescence. TPAEDFMRFamide immunoreactivity is present in cells of the ventral
ganglion stained with FMRFamide antisera. The schematic on the left depicts a larval central
nervous system stained with TPAEDFMRFamide antisera. The boxed section of the ventral
ganglion represents the immunofluorescence shown on the right. FMRFamide-stained cells are
labeled with secondary antisera conjugated to FITC (green), while the TPAEDFMRFamide-
containing cells are labeled with a secondary antisera conjugated to Cy3 (red). The yellow signal
demonstrates that TPAEDFMRFamide is expressed in a subset of cells also stained with FMRF-
amide antisera. (Lower) TPAEDFMRFamide/FMRFamide third-instar larval gastrointestinal tract
double-label immunofluorescence. TPAEDFMRFamide immunoreactivity is present in cells of the
anterior midgut that are stained with FMRFamide antisera. Cy3-conjugated secondary antisera (red)
recognize TPAEDFMRFamide antisera and FITC (green)-labeled secondary antisera recognize
FMRFamide antisera. The yellow fluorescence of the cells is a result of TPAEDFMRFamide
antisera binding antigen in a subset of cells stained with FMRFamide antisera. Bar5 50 mm.
subesophageal ganglion, and several cells in the su-
perior protocerebrum (Nichols et al., 1995a). The
thoracic ganglia cells stained by DPKQDFMRFamide
antisera are more dorsal than those stained by
TPAEDFMRFamide (Nichols et al., 1995a). SDN-
FMRFamide immunoreactivity is present in several
cells of the subesophageal ganglion, but is not present
in the cells of the nerve cord (Nichols et al., 1995b).
The patterns of expression of both DPKQDFMRF-
amide and SDNFMRFamide are subsets of FMRF-
amide antisera staining and are present in cells
containing the FMRFamide polyprotein precursor
(Nichols et al., 1995a,b).
TPAEDFMRFamide-immunoreactive material is
expressed in the central nervous system and gastroin-
testinal tract in all stages of development, suggesting
that the peptide has important roles in physiology.
Double-immunolabeling data indicate that TPAED-
FMRFamide antisera staining is a subset of FMRF-
amide immunoreactivity (Fig. 9) and TPAEDFMRF-
amide appears to be present in cells containing the
FMRFamide precursor (Schneider et al., 1993). In
addition, TPAEDFMRFamide-immunoreactive mate-
rial does not coexist with DPKQDFMRFamide and
SDNFMRFamide (Fig. 10) (Nichols et al., 1995a,b).
These data support the conclusion that differential
posttranslational processing of theDrosophilaFMR-
Famide polypeptide precursor to produce unique cel-
lular expression patterns is a means by which to
regulate the distribution of structurally related pep-
tides that may have diverse and different activities.
This study was supported by National Science Founda-
tion Grant IBN 9724141 to RN.
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